Cargando…
HIV-1 Viremia Prevents the Establishment of Interleukin 2–producing HIV-specific Memory CD4(+) T Cells Endowed with Proliferative Capacity
CD4(+) T cell responses are associated with disease control in chronic viral infections. We analyzed human immunodeficiency virus (HIV)-specific responses in ten aviremic and eight viremic patients treated during primary HIV-1 infection and for up to 6 yr thereafter. Using a highly sensitive 5-(and-...
Autores principales: | Younes, Souheil-Antoine, Yassine-Diab, Bader, Dumont, Alain R., Boulassel, Mohamed-Rachid, Grossman, Zvi, Routy, Jean-Pierre, Sékaly, Rafick-Pierre |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194146/ https://www.ncbi.nlm.nih.gov/pubmed/14676302 http://dx.doi.org/10.1084/jem.20031598 |
Ejemplares similares
-
Autologous HIV-1 Clade-B Nef Peptides Elicit Increased Frequency, Breadth and Function of CD8(+) T-Cells Compared to Consensus Peptides
por: Doroudchi, Mehrnoosh, et al.
Publicado: (2012) -
CD160 and PD-1 Co-Expression on HIV-Specific CD8 T Cells Defines a Subset with Advanced Dysfunction
por: Peretz, Yoav, et al.
Publicado: (2012) -
Low-Level Viremia Predicts Virological Failure in HIV-Infected Omani
Patients Receiving Antiretroviral Therapy
por: Gaifer, Zied, et al.
Publicado: (2020) -
P18-13 LB. Immunogenicity of an autologous dendritic cell anti-HIV therapy in HIV-1 infected individuals
por: Yassine Diab, B, et al.
Publicado: (2009) -
The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?
por: Sekaly, Rafick-Pierre
Publicado: (2008)